Lupin, Zentiva Partner for Certolizumab Pegol Biosimilar
July 9, 2025 15:14
Lupin and Zentiva announce a license and supply agreement for the commercialization of biosimilar Certolizumab Pegol across global markets, aiming to improve patient access to cost-effective...